ReP USP - Resultado da busca

Trabalho de evento-resumo
SLC22A1 polymorphisms are not associated with cytogenetic and molecular response to imatinib mesylate in chronic myelogenous leukemia patients (2011)
Guerra-Shinohara, Elvira Maria ; Bueno, Carolina Tosin; Lima, Luciene Terezinha de; Vivona, Douglas; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Chiattone, Carlos Sérgio; Zanichelli, Maria Aparecida
Source: Abstracts. Conference titles: Annual Congress of the European Hematology Association (EHA). Unidade: FCF
Subjects: POLIMORFISMO, LEUCEMIA MIELOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUERRA-SHINOHARA, Elvira Maria et al. SLC22A1 polymorphisms are not associated with cytogenetic and molecular response to imatinib mesylate in chronic myelogenous leukemia patients. 2011, Anais.. Hague: European Hematology Association (EHA), 2011. . Acesso em: 21 out. 2024.
APA
Guerra-Shinohara, E. M., Bueno, C. T., Lima, L. T. de, Vivona, D., Hirata, R. D. C., Hirata, M. H., et al. (2011). SLC22A1 polymorphisms are not associated with cytogenetic and molecular response to imatinib mesylate in chronic myelogenous leukemia patients. In Abstracts. Hague: European Hematology Association (EHA).
NLM
Guerra-Shinohara EM, Bueno CT, Lima LT de, Vivona D, Hirata RDC, Hirata MH, Luchessi AD, Chiattone CS, Zanichelli MA. SLC22A1 polymorphisms are not associated with cytogenetic and molecular response to imatinib mesylate in chronic myelogenous leukemia patients. Abstracts. 2011 ;[citado 2024 out. 21 ]
Vancouver
Guerra-Shinohara EM, Bueno CT, Lima LT de, Vivona D, Hirata RDC, Hirata MH, Luchessi AD, Chiattone CS, Zanichelli MA. SLC22A1 polymorphisms are not associated with cytogenetic and molecular response to imatinib mesylate in chronic myelogenous leukemia patients. Abstracts. 2011 ;[citado 2024 out. 21 ]
Trabalho de evento-resumo
Haplotype for polymorphisms C1236T, C3435T and C2677T/A in MDR1 gene is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib (2011)
Guerra-Shinohara, Elvira Maria ; Vivona, Douglas; Bueno, Carolina Tosin; Lima, Luciene Terezinha de; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Zanichelli, Maria Aparecida; Chiattone, Carlos Sérgio
Source: Abstracts. Conference titles: Annual Congress of the European Hematology Association (EHA). Unidade: FCF
Subjects: POLIMORFISMO, LEUCEMIA MIELOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUERRA-SHINOHARA, Elvira Maria et al. Haplotype for polymorphisms C1236T, C3435T and C2677T/A in MDR1 gene is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. 2011, Anais.. Hague: European Hematology Association (EHA), 2011. . Acesso em: 21 out. 2024.
APA
Guerra-Shinohara, E. M., Vivona, D., Bueno, C. T., Lima, L. T. de, Hirata, R. D. C., Hirata, M. H., et al. (2011). Haplotype for polymorphisms C1236T, C3435T and C2677T/A in MDR1 gene is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. In Abstracts. Hague: European Hematology Association (EHA).
NLM
Guerra-Shinohara EM, Vivona D, Bueno CT, Lima LT de, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS. Haplotype for polymorphisms C1236T, C3435T and C2677T/A in MDR1 gene is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. Abstracts. 2011 ;[citado 2024 out. 21 ]
Vancouver
Guerra-Shinohara EM, Vivona D, Bueno CT, Lima LT de, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS. Haplotype for polymorphisms C1236T, C3435T and C2677T/A in MDR1 gene is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. Abstracts. 2011 ;[citado 2024 out. 21 ]
Trabalho de evento-resumo
MTHFR gene polymorphisms are not associated with hematologic alterations in women with recurrent pregnancy losses (2011)
Guerra-Shinohara, Elvira Maria ; Giusti, Kelma Cordeiro da Silva; Lázaro, Robson José; Monteiro, N; Bertinato, F; Seino, Fernanda Midori; Britto, J; Cavalcante, S; Carvalho, M; Amorim Filho, Antônio; Zugaib, Marcelo
Source: Abstracts. Conference titles: Annual Congress of the European Hematology Association (EHA). Unidades: FCF, FM
Subjects: POLIMORFISMO, ABORTO ESPONTÂNEO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUERRA-SHINOHARA, Elvira Maria et al. MTHFR gene polymorphisms are not associated with hematologic alterations in women with recurrent pregnancy losses. 2011, Anais.. Hague: European Hematology Association (EHA), 2011. . Acesso em: 21 out. 2024.
APA
Guerra-Shinohara, E. M., Giusti, K. C. da S., Lázaro, R. J., Monteiro, N., Bertinato, F., Seino, F. M., et al. (2011). MTHFR gene polymorphisms are not associated with hematologic alterations in women with recurrent pregnancy losses. In Abstracts. Hague: European Hematology Association (EHA).
NLM
Guerra-Shinohara EM, Giusti KC da S, Lázaro RJ, Monteiro N, Bertinato F, Seino FM, Britto J, Cavalcante S, Carvalho M, Amorim Filho A, Zugaib M. MTHFR gene polymorphisms are not associated with hematologic alterations in women with recurrent pregnancy losses. Abstracts. 2011 ;[citado 2024 out. 21 ]
Vancouver
Guerra-Shinohara EM, Giusti KC da S, Lázaro RJ, Monteiro N, Bertinato F, Seino FM, Britto J, Cavalcante S, Carvalho M, Amorim Filho A, Zugaib M. MTHFR gene polymorphisms are not associated with hematologic alterations in women with recurrent pregnancy losses. Abstracts. 2011 ;[citado 2024 out. 21 ]

USP Schools

ReP

Filtros

Authors